Novartis And UK Launch Partnership On Groundbreaking Cardiovascular Prevention Trial
00:00 EST 12 Feb 2020 |
SCRIP
Partnership includes provision for fast-tracked uptake of inclisiran in England, if NICE finds it cost effective
More From BioPortfolio on "Novartis And UK Launch Partnership On Groundbreaking Cardiovascular Prevention Trial"